CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Technological advancements in ablation devices and sprouting number of hospitals,
surgical, ablation centers
4.1.2. Increasing population base for cancer patients and the growing geriatric population
globally
4.1.3. Growing demand for minimally invasive surgeries
4.1.4. Growing awareness about ablation procedures over conventional therapeutic and
surgical procedures
4.2. Market Restraints & Challenges
4.2.1. Ongoing healthcare reforms in developed economies like the U.S.
4.2.2. Complications associated with tumor ablation therapy and cost containment measures
taken by various governments
CHAPTER 5 GLOBAL TUMOR ABLATION MARKET – BY MODE OF
TREATMENT
5.1. Laparoscopic Ablation
5.2. Percutaneous Ablation
5.3. Surgical Ablation
CHAPTER 6 GLOBAL TUMOR ABLATION MARKET – BY TECHNOLOGY
6.1. Microwave Ablation
6.2. Cryoablation
6.3. Radiofrequency Ablation
6.4. Others
CHAPTER 7 GLOBAL TUMOR ABLATION MARKET – BY APPLICATION
7.1. Kidney Cancer
7.2. Bone Metastasis
7.3. Liver Cancer
7.4. Lung Cancer
7.5. Others
CHAPTER 8 GLOBAL TUMOR ABLATION MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL TUMOR ABLATION MARKET - COMPANY PROFILES
9.1. Boston Scientific Corporation
9.2. NeuWave Medical, Inc.
9.3. EDAP TMS S.A.
9.4. Mermaid Medical A/S
9.5. Sonacare Medical, LLC
9.6. MISONIX, Inc.
9.7. Medtronic, PLC.
9.8. AngioDynamics, Inc.
9.9. HealthTronics, Inc.
9.10. BTG PLC
CHAPTER 10 GLOBAL TUMOR ABLATION MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
